If You're Buying Cannabis Stocks Again... Start Here

[] After a tough year, cannabis stocks are back in focus with 2022 around the corner. We look at the top cannabis stock to own in the new year and discuss the importance of profitability in the space. [View in browser]( . After a tough year, cannabis stocks are back in focus with 2022 around the corner. We look at the top cannabis stock to own in the new year and discuss the importance of profitability in the space. [View in browser]( . . [] [Havens Investment Letter] [] [Havens Investment Letter] [] [] [] 70% Win Rate Trading the Crown Jewel of Tech Stocks That is the power of the remarkable system that California tech genius Micah Lamar calls "the Perfect Apple Trade." Recently, he even identified a 30% on AAPL over four days, even while the S&P 500 tanked. [See this incredible system in action here]( [] --------------------------------------------------------------- [] 70% Win Rate Trading the Crown Jewel of Tech Stocks That is the power of the remarkable system that California tech genius Micah Lamar calls "the Perfect Apple Trade." Recently, he even identified a 30% on AAPL over four days, even while the S&P 500 tanked. [See this incredible system in action here]( [] --------------------------------------------------------------- [] [] If You're Buying Cannabis Stocks Again... Start Here [Garrett Pic]Dear Investor, Overall, 2021 was a horrible year for cannabis investors. Despite the wave of legalization in states across the nation, optimism about cannabis falling off the Schedule I list, and greater legalization fronts in other nations across Europe and North America, it was an ugly performance. If we look at the performance of cannabis stocks over the last year, the numbers are grave. For example, Grow Generation Corp. (GRWG) shares are off 67.5% since the start of the year. Aurora Cannabis (ACB) has plunged 42% since the start of the year. And shares of Tilray Inc. (TLRY) are off nearly 90% from February 2021 highs. But let's take a step back. With this significant drop across the board, it's time to be contrarian and start to look for buying opportunities. I'm outlining my top pick right now. Here's What To Own If you're going to speculate on cannabis, at least do it the right way. We look at this world through the lens of profitability, takeover potential, and existing strength on the market. For my money, the lone cannabis stock I'd like to own is cannabis operator Trulieve Cannabis Corp. (TCNNF). As of Nov. 15, 2020, the company owns 155 dispensaries in 11 states. With 14 straight quarters of profitability, the company has vertically integrated with one goal in mind: Broad legalization in the United States. As 2022 begins, Trulieve is waiting for Congress to take action. In today's political climate, there are multiple bills on the table that might lead to greater legalization across the United States and Europe. Politicians in New Hampshire have filed six new bills that would potentially legalize cannabis next year. Meanwhile, Forbes reports that Germany, Italy, Portugal, Luxembourg, and Switzerland are all exploring potential legalization efforts. Even though Trulieve doesn't have a foothold in these markets (at least not yet), legalization efforts will spur investor and speculative capital once again. Now, Trulieve is a Canadian company, but it has found its success here in the United States over the last decade. Trulieve is a large, multi-state cannabis operator. Founded in Florida, the company aims to become one of the largest cannabis retailers in the nation. Although it represents 20% of the physical real estate in Florida, the company owns about 50% of the Florida medicinal market. That's an incredible starting point. There are a few things that really stand out in Trulieve. Aside from the incredible marketshare in Florida, a state with the fourth-largest population in the nation, Trulieve also holds licenses to operate in California, Nevada, Massachusetts, Pennsylvania, Massachusetts, Georgia, Colorado, Arizona, Maryland, Connecticut, and West Virginia . I anticipate that its footprint will continue to expand across the country. Second, the company's insiders represent a huge stake of shareholders. In fact, there's no true record of informed sales of stock by executives. These owners are "in it to win it." That level of confidence in the long-term future should give investors significant optimism. Even when the stock pulled back in 2021, insiders loaded up on the stock. In September, we saw informative purchases by the Chief Financial Officer, the Chairman and CEO, the President, and other executives. Finally, here's a really important metric that few investors ignore. As I noted, the company is based in Canada. Shares are listed over the counter at the moment under the ticker ([OTC: TCNFF](. The company has not joined an exchange like the Nasdaq or NYSE. This is important because many other competitors are already trading on these exchanges here in the United States. However, Trulieve started the process of being deemed a US domestic issuer under United States securities laws. That means it must meet SEC reporting requirements (which started this year). This could signal that the company plans to list on US exchanges in the months ahead. Uplisting on the NASDAQ or NYSE would be a major step for the company as it would likely be added to a wealth of exchange-traded funds and other funds that trade baskets of stocks. Right now, Trulieve has an average price target on Wall Street of $66.30. That represents a potential upside of nearly 160%. I'm a little more conservative than this upside. I think that Jefferies' latest price target of roughly $47.55 is more in line with expectations. Even at $45 per share, that would be a 76% gain by the end of 2022. Enjoy your day, [GarrettSig] Garrett {NAME} Chief Analyst, American Markets [] --------------------------------------------------------------- [] [] If You're Buying Cannabis Stocks Again... Start Here [Garrett Pic]Dear Investor, Overall, 2021 was a horrible year for cannabis investors. Despite the wave of legalization in states across the nation, optimism about cannabis falling off the Schedule I list, and greater legalization fronts in other nations across Europe and North America, it was an ugly performance. If we look at the performance of cannabis stocks over the last year, the numbers are grave. For example, Grow Generation Corp. (GRWG) shares are off 67.5% since the start of the year. Aurora Cannabis (ACB) has plunged 42% since the start of the year. And shares of Tilray Inc. (TLRY) are off nearly 90% from February 2021 highs. But let's take a step back. With this significant drop across the board, it's time to be contrarian and start to look for buying opportunities. I'm outlining my top pick right now. Here's What To Own If you're going to speculate on cannabis, at least do it the right way. We look at this world through the lens of profitability, takeover potential, and existing strength on the market. For my money, the lone cannabis stock I'd like to own is cannabis operator Trulieve Cannabis Corp. (TCNNF). As of Nov. 15, 2020, the company owns 155 dispensaries in 11 states. With 14 straight quarters of profitability, the company has vertically integrated with one goal in mind: Broad legalization in the United States. As 2022 begins, Trulieve is waiting for Congress to take action. In today's political climate, there are multiple bills on the table that might lead to greater legalization across the United States and Europe. Politicians in New Hampshire have filed six new bills that would potentially legalize cannabis next year. Meanwhile, Forbes reports that Germany, Italy, Portugal, Luxembourg, and Switzerland are all exploring potential legalization efforts. Even though Trulieve doesn't have a foothold in these markets (at least not yet), legalization efforts will spur investor and speculative capital once again. Now, Trulieve is a Canadian company, but it has found its success here in the United States over the last decade. Trulieve is a large, multi-state cannabis operator. Founded in Florida, the company aims to become one of the largest cannabis retailers in the nation. Although it represents 20% of the physical real estate in Florida, the company owns about 50% of the Florida medicinal market. That's an incredible starting point. There are a few things that really stand out in Trulieve. Aside from the incredible marketshare in Florida, a state with the fourth-largest population in the nation, Trulieve also holds licenses to operate in California, Nevada, Massachusetts, Pennsylvania, Massachusetts, Georgia, Colorado, Arizona, Maryland, Connecticut, and West Virginia . I anticipate that its footprint will continue to expand across the country. Second, the company's insiders represent a huge stake of shareholders. In fact, there's no true record of informed sales of stock by executives. These owners are "in it to win it." That level of confidence in the long-term future should give investors significant optimism. Even when the stock pulled back in 2021, insiders loaded up on the stock. In September, we saw informative purchases by the Chief Financial Officer, the Chairman and CEO, the President, and other executives. Finally, here's a really important metric that few investors ignore. As I noted, the company is based in Canada. Shares are listed over the counter at the moment under the ticker ([OTC: TCNFF](. The company has not joined an exchange like the Nasdaq or NYSE. This is important because many other competitors are already trading on these exchanges here in the United States. However, Trulieve started the process of being deemed a US domestic issuer under United States securities laws. That means it must meet SEC reporting requirements (which started this year). This could signal that the company plans to list on US exchanges in the months ahead. Uplisting on the NASDAQ or NYSE would be a major step for the company as it would likely be added to a wealth of exchange-traded funds and other funds that trade baskets of stocks. Right now, Trulieve has an average price target on Wall Street of $66.30. That represents a potential upside of nearly 160%. I'm a little more conservative than this upside. I think that Jefferies' latest price target of roughly $47.55 is more in line with expectations. Even at $45 per share, that would be a 76% gain by the end of 2022. Enjoy your day, [GarrettSig] Garrett {NAME} Chief Analyst, American Markets --------------------------------------------------------------- [] A Chance To MAKE $490 EVERY DAY THE MARKET IS OPEN? [rob booker]( [Click Now For Details]( --------------------------------------------------------------- [] [] A Chance To MAKE $490 EVERY DAY THE MARKET IS OPEN? [rob booker]( [Click Now For Details]( --------------------------------------------------------------- [] [] [] Now Available: The Brainchild of Wall Street Mavericks — the Perfect Apple Trade If you ever thought that it’s way too late to see significant movement in major stocks like AAPL... You need to think again… The Perfect Apple Trade Has Been Discovered Thanks to the help of a maverick group of former Wall Street traders… and a state-of-the-art artificial intelligence platform… California tech wiz and renowned trader Micah Lamar has uncovered obscure “trade cycles” in AAPL shares capable of signaling major movement… All in a matter of days... These Aren’t Common Results Nearly all market analysts are clueless about these moves… But Micah’s proprietary system has been able to predict significant moves in AAPL stock… over and over again. Now, You Can See the System for Yourself! He’ll walk you through his AAPL system step-by-step… and answer the most common questions he sees... You’ll even be able to gain access to Micah’s proprietary Apple trading tool… Plus, you’ll see the remarkable results Micah’s system has returned, just by placing one trade on iconic Apple Inc., the crown jewel of tech stocks… [Click here to gain immediate access to this presentation]( You’ll be one of the lucky few to see the Perfect Apple Trade system yourself… And meet the brilliant inventor behind this system… [Catch it all here]( --------------------------------------------------------------- [] [] [] [] Now Available: The Brainchild of Wall Street Mavericks — the Perfect Apple Trade If you ever thought that it’s way too late to see significant movement in major stocks like AAPL... You need to think again… The Perfect Apple Trade Has Been Discovered Thanks to the help of a maverick group of former Wall Street traders… and a state-of-the-art artificial intelligence platform… California tech wiz and renowned trader Micah Lamar has uncovered obscure “trade cycles” in AAPL shares capable of signaling major movement… All in a matter of days... These Aren’t Common Results Nearly all market analysts are clueless about these moves… But Micah’s proprietary system has been able to predict significant moves in AAPL stock… over and over again. Now, You Can See the System for Yourself! He’ll walk you through his AAPL system step-by-step… and answer the most common questions he sees... You’ll even be able to gain access to Micah’s proprietary Apple trading tool… Plus, you’ll see the remarkable results Micah’s system has returned, just by placing one trade on iconic Apple Inc., the crown jewel of tech stocks… [Click here to gain immediate access to this presentation]( You’ll be one of the lucky few to see the Perfect Apple Trade system yourself… And meet the brilliant inventor behind this system… [Catch it all here]( --------------------------------------------------------------- [] [] Article Recap - [If You're Buying Cannabis Stocks Again... Start Here](#i572731) - [Now Available: The Brainchild of Wall Street Mavericks — the Perfect Apple Trade](#155238) --------------------------------------------------------------- [] Article Recap - [If You're Buying Cannabis Stocks Again... Start Here](#i572731) - [Now Available: The Brainchild of Wall Street Mavericks — the Perfect Apple Trade](#155238) --------------------------------------------------------------- [] © 2021 Godesburg Financial Publishing, Inc. DISCLAIMER: COMMUNICATIONS FROM GODESBURG FINANCIAL PUBLISHING (GFP) ARE FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY – NOT INVESTMENT ADVICE: GFP and all the services it offers are for educational and informational purposes only and should NOT be understood to be securities-related offers or solicitations. None of GFP’s communications should be considered or used as personalized investment advice. GFP recommends that you speak with a licensed professional before making any investment decision. RESULTS PRESENTED ARE NOT NECCESSARILY TYPICAL OR VERIFIED: GFP communications may include information regarding the historical trading performance of gurus in their services (all verified by a third party), as well as testimonials of non-employees depicting profitable investments and trades that are believed to be true based on the representations of the persons providing the testimonial of their own free will. Please be aware that the claims regarding investing or trading results of non-employees are not tracked by GFP nor can they be verified. As always, past performance is not necessarily indicative of future results. Therefore, results presented in this email should NOT be considered TYPICAL. Actual results can and will vary based on everything from experience, ability, risk mitigation practices, and market volatility... to the amount of money exposed in the investment or trade. Investing and trading are speculative and carry serious risk. You may lose some, all - or possibly more - than your original investment or trade. GODESBURG FINANCIAL PUBLISHING IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER: GFP, including its owners and employees, are NOT registered as securities broker-dealers, brokers, or any sort of registered investment advisors with the U.S. Securities and Exchange Commission, any state securities regulatory authorities, or any self-regulatory organizations. GODESBURG FINANCIAL PUBLISHING EMPLOYEES MAY HOLD SECURITIES DISCUSSED: If a writer holds any securities in a communication, it will be disclosed along with the information on the potential investment or trade. HIR, its owners or employees, have not been - or ever will be - paid by the issuer of a security mentioned in our services or communications. GFP, its owners and employees are paid entirely or in part from commissions based on sales of their services to subscribers. For more information, please visit [our disclaimer page here.]( Sent to: [{EMAIL}](mailto:) [Unsubscribe]( Godesburg Financial Publishing Inc., 251 Little Falls Drive, Wilmington, DE 19808, United States [] © 2021 Godesburg Financial Publishing, Inc. DISCLAIMER: COMMUNICATIONS FROM GODESBURG FINANCIAL PUBLISHING (GFP) ARE FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY – NOT INVESTMENT ADVICE: GFP and all the services it offers are for educational and informational purposes only and should NOT be understood to be securities-related offers or solicitations. None of GFP’s communications should be considered or used as personalized investment advice. GFP recommends that you speak with a licensed professional before making any investment decision. RESULTS PRESENTED ARE NOT NECCESSARILY TYPICAL OR VERIFIED: GFP communications may include information regarding the historical trading performance of gurus in their services (all verified by a third party), as well as testimonials of non-employees depicting profitable investments and trades that are believed to be true based on the representations of the persons providing the testimonial of their own free will. Please be aware that the claims regarding investing or trading results of non-employees are not tracked by GFP nor can they be verified. As always, past performance is not necessarily indicative of future results. Therefore, results presented in this email should NOT be considered TYPICAL. Actual results can and will vary based on everything from experience, ability, risk mitigation practices, and market volatility... to the amount of money exposed in the investment or trade. Investing and trading are speculative and carry serious risk. You may lose some, all - or possibly more - than your original investment or trade. GODESBURG FINANCIAL PUBLISHING IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER: GFP, including its owners and employees, are NOT registered as securities broker-dealers, brokers, or any sort of registered investment advisors with the U.S. Securities and Exchange Commission, any state securities regulatory authorities, or any self-regulatory organizations. GODESBURG FINANCIAL PUBLISHING EMPLOYEES MAY HOLD SECURITIES DISCUSSED: If a writer holds any securities in a communication, it will be disclosed along with the information on the potential investment or trade. HIR, its owners or employees, have not been - or ever will be - paid by the issuer of a security mentioned in our services or communications. GFP, its owners and employees are paid entirely or in part from commissions based on sales of their services to subscribers. For more information, please visit [our disclaimer page here.]( Sent to: [{EMAIL}](mailto:) [Unsubscribe]( Godesburg Financial Publishing Inc., 251 Little Falls Drive, Wilmington, DE 19808, United States